Mbb Public Markets I LLC Crinetics Pharmaceuticals, Inc. Transaction History

Mbb Public Markets I LLC

  • $4.85 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$25.62 - $37.07 $1.48 Million - $2.14 Million
57,731 Added 663.42%
66,433 $2.36 Million
Q3 2023

Nov 14, 2023
SELL
$15.97 - $30.59 $65,477 - $125,419
-4,100 Reduced 32.03%
8,702 $258,000
Q2 2023

Aug 14, 2023
BUY
$15.73 - $23.6 $17,303 - $25,960
1,100 Added 9.4%
12,802 $230,000
Q1 2023

May 15, 2023
BUY
$15.31 - $21.1 $179,157 - $246,912
11,702 New
11,702 $187,000

Others Institutions Holding CRNX

# of Institutions
244
Shares Held
78.2M
Call Options Held
268K
Put Options Held
197K
View Full List

About Crinetics Pharmaceuticals, Inc.

CRNX Quotes by TradingView
  • Ticker CRNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,752,800
  • Market Cap $2.73B
  • Description
  • Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...
More about CRNX
Track This Portfolio

Track Mbb Public Markets I LLC Portfolio

Follow Mbb Public Markets I LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mbb Public Markets I LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mbb Public Markets I LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email